Xylitol has been used in several countries as a parenteral nutrient. Adverse reactions to intravenous xylitol infusions have been reported with calcium oxalate crystal deposition within the walls of the intracranial arteries and extensively in the kidneys (Evans et al., 1973; Schroder et al., 1974) . Similar but more widespread calcium oxalate deposits occur in primary hyperoxaluria (Scowen et al., 1959) . The urinary excretion of organic acids by xylitol-infused patients was examined and compared to that by glucose-infused patients, in order to define any alterations that might be related to the organic acidurias observed in patients with primary hyperoxaluria types I and I1 (hyperoxaluria with hyperglycollic aciduria and hyperglyoxylic aciduria, and hyperoxaluria with hyper-Lglyceric aciduria respectively).
Quantitative extraction and g.l.c., and g.1.c.-mass-spectrometric methods were used. Four out of five of the xylitol-infused patients showed grossly increased excretions of glycollic acid and of threonic acid [2,3,4trihydroxy(threo)butanoic acid]. There was no detectable increase in the excretion of oxalic acid, glyoxylic acid, or glyceric acid. S. Hauschildt, R. A. Chalmers, A. M. Lawson, K., Schulthis & R. W. E. Watts (unpublished work) found that xylitol infusion did not increase blood oxalate concentrations.
Xylitol is metabolized in man to D-XylUlOSe, D-xylulose Sphosphate, and thence to glucose via the pentose phosphate pathway. Transketolase (sedoheptulose 7-phosphate-D-glyceraldehyde 3-phosphate glycolaldehydetransferase, EC 2.2.1 .l) intervenes twice in the metabolism of pentose phosphates, once to form glyceraldehyde 3-phosphate and sedoheptulose 7-phosphate from xylulose 5-phosphate and ribose 5-phosphate, and again to form fructose 6-phosphate and glyceraldehyde 3-phosphate from another molecule of xylulose 5-phosphate and erythrose 4-phosphate (Fig. 1) .
In these reactions the enzyme catalyses the stereospecific reversible transfer of a glycolaldehyde moiety from a donor ketose to an acceptor aldose. Besides xylulose Sphosphate, suitable donors include hydroxypyruvate, L-erythrulose, D-fructose Gphosphate and D-sedoheptulose 7-phosphate. Suitable acceptors include, in addition to D-ribose 5-phosphate and D-erythrose +phosphate, glycolaldehyde (-+ L-erythrulose), D-glyceraldehyde 3-phosphate (-+ D-XylUlOSe 5-phosphate) and formaldehyde (-+ dihydroxyacet one).
The transketolase reaction requires thiamin pyrophosphate as an essential cofactor, and Mgz+ ions, and the mechanism of the reaction has been studied in oitro in conjunction with other thiamin pyrophosphate-catalysed enzyme systems, notably the decarboxylation of a-0x0 acids such as pyruvate, 2-oxoglutatate, and the branched-chain a-0x0 acids derived from valine, leucine and isoleucine (Ullrich et al., 1968; Krampitz, 1969 ., 1967) who demonstrated the formation in vitro of the free compound by heart muscle pyruvate oxidase and by yeast transketolase from hydroxypyruvate, thiamin pyrophosphate and Mg2+, and from the non-enzymic reaction of thiamin pyrophosphate and excess of glycolaldehyde. Studies in vitro have also shown that some free glycolaldehyde may result during the transketolase reaction, with exchange occurring between free glycolaldehyde in solution and the enzyme-bound complex (Datta & Racker, 1961 ). This may arise from a mechanism of the type shown in Fig. 2 , with the equilibrium shown generally favouring the formation of the thiamin pyrophosphate-activated aldehyde. However, in the presence of oxidizing systems such as pyruvate oxidase and NAD+ (Pohlandt et al., 1967) or 2,6-dichlorophenol-indophenol (da Fonesca-Wollheim et al., 1962), free glycollic acid may arise by the irreversible oxidation of the free glycoaldehyde.
The present work has demonstrated the urinary excretion of large amounts of glycollic acid by xylitol-infused patients. This could arise from free glycolaldehyde due to overload of the transketolase reaction, and of possible aldose acceptors, by the large amounts of xylulose 5-phosphate presented to the enzyme system. The free glycolaldehyde could then be oxidized to glycollic acid by the action of, e.g., aldehyde dehydrogenase (aldehyde-NAD+ oxidoreductase, EC 1.2.1.3) (Racker, Some of the free glycolaldehyde may act as an acceptor in the transketolase reactions to give Lerythrulose, as has been demonstrated in uitro (Datta & Racker, 1961) . It is suggested that the occurrence of increased amounts of threonic acid in the urine of xylitol-infused patients is due to the conversion of L-erythrulose into D-erythrose and D-threose (4-phosphates) and subsequent oxidation. The preponderance of threonic acid may be due to the alternative metabolic pathways available to Derythrose Cphosphate (Fig. 1) . Alternatively, it is possible that threonic acid could arise from the use of glyoxylic acid as an acceptor in the transketolase reaction. We suggest that the present findings given support to the concept that in vivo the thiamin pyrophosphate-activated aldehyde is an intermediate in the transketolase reaction. The present observation of hyperglycollic aciduria without hyperoxaluria, in association with xylitol infusion, suggests that either glycollate is not oxidized to glyoxylate to an appreciable extent in vivo, or that any glyoxylate formed is immediately transaminated to glycine or decarboxylated synergistically with 2-oxoglutarate. Thus it appears that glycollate oxidase (glycollate-oxygen oxidoreductase, EC 1.1.3.1) is relatively unimportant in vivo, and that the equilibrium of glyoxylate reductase (glycollate-NAD+ oxidoreductase, EC 1.1.1.26) favours the reductive reaction. This is compatible with the report that [14C]glycollate was a less efficient precursor of [14C]oxalate and["C]-glyoxylate in the studies on man in vivo (Hockaday et al., 1964) .
The present work suggests that the renal and extra-renal oxalosis observed in some xylitol-infused patients (Evans et al., 1973; Schroder et al., 1974 ) is due to factors other than the metabolism of xylitol itself. Impaired renal function, the concentration or osmolality of the infused solutions, and the rate of infusion are factors which merit consideration from this viewpoint.
